Public Policy Newsletter

Biocom Policy Newsletter More Accessible for You
August 22nd, 2019 – We are excited to announce that the Public Policy Newsletter is now available on the Biocom website and no longer requires your login to the Member Community.

Read Story

PUBLIC POLICY NEWSLETTER

Cover StoryView All

Biocom Policy Newsletter More Accessible for You

Join Us for our Annual Biocom PAC Elected Officials and Candidates Reception on August 15

Biocom DC Reception Recognized California Congressional Delegation and Life Science Community

Biocom Hosts Roundtable with USPTO Director Andrei Iancu

Biocom Successfully Advocates for Digital Health Innovation during 2019 Fly-In

Congressman Lou Correa Visits Biocom Board

Shutdown temporarily averted; Impact on FDA

A Year in Review from Biocom’s Public Policy Team

Regional AffairsView All

Biocom Hosts Elected Officials and Staff at LA’s HATCHlabs

Share Your Thoughts on the South San Francisco General Plan Update

Life Science Mayors Roundtable with the Cities of Fremont, Newark, Union City, and Milpitas

Save the Date: Biocom & South San Francisco Transportation Workshop

San Diego Creates New Zone for Mixed Use Developments

San Diego City Council Approves New Large-scale Development Project

San Diego Passes New Guidelines to Enroll in Guaranteed Water for Industry

Thoughtful Discussion at Our Roundtable with Carlsbad’s New Chief Innovation Officer

State AffairsView All

California Law Requires Women on Corporate Boards by December 31, 2019

Great Networking at the Annual Biocom PAC Elected Officials Reception

Assembly Select Committee on Biotechnology to Hold Hearing on Precision Medicine in CA

California DHCS Announces Second Medi-Cal Rx Pharmacy Carve Out Advisory Group Meeting

State Legislature Returns From Break, Enters Last Month of Session

RFP Issued To Implement Governor Newsom’s Single Purchaser Drug Plan

State Legislature Recesses till August 12

Biocom Fights on Behalf of Members on Sacramento Legislation

Federal AffairsView All

Successful Roundtable with Congressman Eric Swalwell

FDA Solicits Industry Input for Office of New Drugs Policy Priorities

Senate Finance Committee Advances Drug Pricing Package

HHS Releases Drug Importation Plan

Biocom to Host Congressional Briefing on Precision Medicine

Biocom is Seeking Comments on the 2020 Medicare Physician Fee Schedule Proposed Rule

CDER Director Announces Big Changes in Drug Development

District Court Blocks Rule Mandating Price Disclosures in DTC Pharmaceutical TV Ads